Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Zacks Investment Research on MSN
OM stock gains on FDA clearance for next-gen Tablo dialysis system
Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, ...
Medical Device Network on MSN
Outset Medical secures FDA clearance for Tablo haemodialysis system
Outset Medical plans to begin shipping the updated platform during the second quarter of 2026.
The next-generation Tablo platform is expected to begin shipping to customers in the second quarter of 2026. Healthcare providers currently using Tablo will be eligible to upgrade to the new ...
Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from ASN Kidney Week, Michael Aragon, MD, the chief medical officer of Outset Medical, ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video from ASN Kidney Week, Michael Aragon, MD, the chief medical officer of Outset Medical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results